Status:
COMPLETED
Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Mental Illness
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study will evaluate the effectiveness of a cognitive behavioral treatment in reducing significant medical risk factors often associated with people who have a serious mental illness and are takin...
Detailed Description
Serious mental illness encompasses a large range of symptoms varying in severity, but generally includes symptoms described as both positive and negative. Positive symptoms include confused thinking, ...
Eligibility Criteria
Inclusion
- Resides in one of the designated group homes
Exclusion
- Sufficiently impaired because of a psychiatric illness, as reflected in mental status in which informed judgment about study participation cannot be assured at the time of study entry
- Medical contraindication to study participation
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT00709345
Start Date
July 1 2006
End Date
July 1 2011
Last Update
April 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.